Zynex(US:ZYXI) Prnewswireยท2025-06-30 13:15Company Leadership Change - Zynex, Inc. announced the appointment of Steven Dyson as Chief Executive Officer, effective August 18, 2025 [1] - Thomas Sandgaard, the founder and Chairman of the Board since 1996, will continue to be actively involved in the company [2] Executive Experience - Steven Dyson brings over 25 years of experience in the medical technology sector, with a strong background in private equity and leadership roles in various healthcare companies [3] - His previous experience includes significant roles in companies such as KCI, Rodenstock, Healthium Medtech, Unilabs, and Neuraxpharm [3] Strategic Focus - The company aims to refocus its business strategy towards a more optimized payer mix and to return to a strong growth trajectory under Dyson's leadership [5] - Dyson expressed enthusiasm about leading Zynex and emphasized the strong foundation built by Sandgaard [5] Company Overview - Zynex develops, manufactures, markets, and sells medical devices for pain management and rehabilitation, as well as non-invasive monitoring systems for hospitals [10]